Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read Article
News
2024
2023
Archive
Search news articles
December 21, 2017
MILLENDO THERAPEUTICS ANNOUNCES ACQUISITION OF ALIZÉ PHARMA SAS TO EXPAND ORPHAN ENDOCRINOLOGY PIPELINE
December 18, 2017
5AM VENTURES APPOINTS AMY BURROUGHS AS EXECUTIVE-IN-RESIDENCE
December 11, 2017
AGC AND KINESTRAL TECHNOLOGIES ANNOUNCE JOINT VENTURES TO ACCELERATE GLOBAL ADOPTION OF HALIO™ SMART-TINTING GLASS
December 7, 2017
PURIGEN BIOSYSTEMS APPOINTS LIFE SCIENCE INDUSTRY VETERAN BARNEY SAUNDERS, PHD AS CHIEF EXECUTIVE OFFICER
November 30, 2017
AKOUOS TO BUILD PREMIER GENE THERAPY COMPANY FOCUSED ON HEARING AND BALANCE DISORDERS
November 29, 2017
SCPHARMACEUTICALS INC. ANNOUNCES CLOSING OF OVER-ALLOTMENT OPTION IN ITS INITIAL PUBLIC OFFERING
November 28, 2017
CIDARA THERAPEUTICS COMPLETES ENROLLMENT IN PHASE 2 STRIVE TRIAL EVALUATING NOVEL ANTIFUNGAL REZAFUNGIN (CD101 IV) IN INVASIVE FUNGAL INFECTIONS
November 21, 2017
BIODESY DELTA SYSTEM ENABLES RESEARCHERS TO DISCOVER NOVEL MECHANISM INVOLVED IN INFECTIOUS DISEASE
November 21, 2017
ARVINAS AND MACROCEUTICS ESTABLISH DEL SCREENING COLLABORATION ON UNDRUGGABLE TARGETS
November 20, 2017
FLEXION THERAPEUTICS ANNOUNCES FULL COMMERCIAL LAUNCH AND NATIONWIDE AVAILABILITY OF ZILRETTA™
1
2
3
…
8
Next Page »